# Nortriptyline for the Treatment of Functional Dyspepsia

> **NCT03652571** · PHASE3 · TERMINATED · sponsor: **Maastricht University Medical Center** · enrollment: 96 (actual)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Nortriptyline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03652571
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-01
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 96 (ACTUAL)
- **Why stopped:** The inclusion of participants went more difficult than initially thought. Preliminary analysis showed that the difference between the groups was great enough to draw conclusions from it, so the trial is terminated prematurely.
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03652571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03652571, "Nortriptyline for the Treatment of Functional Dyspepsia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03652571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*